Wells Fargo & Company Heart Test Laboratories, Inc. Put Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HSCS
# of Institutions
24Shares Held
1.55MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA192KShares$846,6110.0% of portfolio
-
Tradition Wealth Management, LLC180KShares$797,6550.0% of portfolio
-
Northern Trust Corp Chicago, IL165KShares$730,9480.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il123KShares$544,0400.0% of portfolio
-
Hrt Financial LP New York, NY122KShares$541,2950.0% of portfolio
About Heart Test Laboratories, Inc.
- Ticker HSCS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,202,550
- Market Cap $36.3M
- Description
- Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...